Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Bayer AG

02 1Ceft Biopharma Sro

03 1Spectrum Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Ibritumomab Tiuxetan

Brand Name : Zevalin

Dosage Form : VIA

Dosage Strength : 1.6mg/ml

Packaging : 4X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

IBRITUMOMAB TIUXETAN

Brand Name : ZEVALIN

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 3.2MG/2ML

Packaging :

Approval Date :

Application Number : 125019

Regulatory Info :

Registration Country : USA

blank

03

Ceft Biopharma Sro

Country
The MedTech Conference
Not Confirmed
arrow

Ceft Biopharma Sro

Country
arrow
The MedTech Conference
Not Confirmed

Ibritumomab Tiuxetan

Brand Name : Zevalin

Dosage Form : Reagent Equipment For Radiopharmaceutical Preparation

Dosage Strength : 1.6MG

Packaging :

Approval Date : 2004-02-18

Application Number : 03264001

Regulatory Info : Authorized

Registration Country : Spain

blank